• Aucun résultat trouvé

Download the presentation

N/A
N/A
Protected

Academic year: 2022

Partager "Download the presentation"

Copied!
34
0
0

Texte intégral

(1)

May 22, 2019

#suicideprevention

#sharehope

Research on suicide and its

prevention: What the current

evidence reveals and topics for

future research

(2)

May 22, 2019

Audio is provided in broadcast mode through your computer speakers. Please ensure your computer

speakers are turned on and turned up.

If you are experiencing technical difficulties please

contact Adobe Connect at: 1-800-422-3623 or click here

(3)
(4)

Presenter

Dr. Sylvanne Daniels

Coordinator, Quebec Network on Suicide, Mood Disorders, and

Related Disorders

(5)

Scoping Review on Suicide Research in Canada and Beyond Since 2000

Sylvanne Daniels, MSc, PhD

Webinar May 22, 2019

A project commissioned by MHCC-PHAC

(6)

Mandate

• Outline the key research topics in the field

• In which areas does Canada contribute to international literature?

• Extensive international literature search from 2000-2017

• Primary focus on systematic reviews

• Particular themes of interest:

Epidemiology

Clinical, demographic, and social factors

Biological factors

Prevention and screening

Treatment and interventions

Follow-up care and postvention

Services research

(7)

C ANADIAN C ONTRIBUTIONS TO

I NTERNATIONAL R ESEARCH ON S UICIDE

(8)

Suicide research in Canada

• Research on suicide is specialized but diverse: biological, clinical, social, etc.

Challenge for bibliometric analysis of the literature

Used of Medical Subject Headings terms; disambiguation of items: suicide (behavioural) vs. “cell suicide,” or apoptosis, and “suicide gene”

• Conducted the bibliometric aspect of the analysis in the PubMed database

Articles published between 2000—2016

Canadian studies identified based author affiliations including “Canada”,

“Canadian”, “British Columbia”, “Alberta”, “Saskatchewan”, “Manitoba”,

“Ontario”, “Quebec”, “Newfoundland”, “Prince Edward Island”, “New

Brunswick”, “Nova Scotia”, “Nunavut”, “Yukon”, or “Northwest Territories”

(9)

Suicide research in Canada: PubMed

0 20 40 60 80 100 120 140 160

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

Number of publications

Year

Canadian Research on Suicide - PubMed N=1,201

(10)

Suicide research in Canada: Distribution of Canadian Research on Suicide by Research Theme

THEME SEARCH TERMS

Epidemiology (epidemiology OR prevalence OR rate) Clinical and

sociodemographic (clinical OR social OR demographic)

Biological (biology OR genetic OR epigenetic OR biomarker OR imaging OR immunology OR lipid OR neurotransmitter OR neurotrophic OR stress)

Prevention and screening (prevention OR screening)

Treatment and intervention (treatment OR intervention OR pharmacotherapy OR psychotherapy) Follow-up and postvention (follow-up OR postvention OR bereavement)

Services (services OR admission)

596

692

292

558

853

117 196

0 100 200 300 400 500 600 700 800 900

Epidemiology Clinical and

sociodemographic Biological Prevention and

screening Treatment and

intervention Follow-up and

postvention Services

Number of publications

PubMed, 2000—2016

(11)

Suicide research in Canada: Distribution of funds per CIHR theme, number of projects funded

Biomedical 8%

Clinical 10%

Health systems/

services 8%

Social/ Cultural/ Environmental/

Population Health 66%

Not applicable/ Specified 8%

Publicly available funding data from the tricouncil funding databases: CIHR, NSERC, SSHERC

Projects funded since the 1999/2000 funding year

Search term “suicid*”, excluding “cancer” and “apoptosis”

429 projects identified, 264 were deemed relevant after inspection of titles and keywords (when available)

$43,751,828 total funding

Projects attributed to each of the four CIHR research themes

(12)

Suicide research in Canada: Comparison of funding and publication output per major theme

$0

$5,000,000

$10,000,000

$15,000,000

$20,000,000

$25,000,000

$30,000,000

$35,000,000

$40,000,000

0 100 200 300 400 500 600 700 800 900

EPI CSF BIO PSC TIN PFU SER GEN IRR

Funding awarded between 2000—2017 ($)

Publications between 2000-2016 (N)

Major Theme

(with overlapping between themes)

(13)

International context of suicide research: PubMed

• Canadian contribution to international has grown:

2.16% of the international publications in 2000

3.52% in 2005

3.95% in 2010

6.12% in 2015

0 500 1000 1500 2000 2500 3000

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

Number of publications

Year

Research on Suicide - PubMed

Non-Canadian (N=28,036) Canadian (N=1,201)

(14)

International context: Proportion of international literature on suicide from Canada, by theme

0.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00 8.00

2000 2001-2005 2006-2010 2011-2015 2016

Percentage of international literature

2000—2016

Epidemiology Clinical and sociodemographic Biological

Prevention and screening Treatment and intervention Follow-up and postvention Services

(15)

L ITERATURE R EVIEW :

S UICIDE AND S UICIDE P REVENTION

R ESEARCH FROM 2000—2017

(16)

Methodology

• Inclusion/exclusion criteria

• Constitution of reference library

• Clean-up of library

• Assessment of articles

• Limitations linked to methodology

(17)

Methodology: Inclusion/exclusion criteria

Inclusion criteria

• Systematic reviews or meta-analyses that addressed suicide or suicide-related outcomes

Suicide-related outcomes: suicidal ideation, suicide attempts, self-harm, self- injury, or deliberate self-harm

• Articles published in 2000 onward

• Articles written in English or in French Exclusion criteria

• Publication dates up to and including 1999

• Language of publication other than English or French

• Homicide-suicide (unless suicide was addressed as an independent outcome)

• Medically-assisted dying (or physician-assisted suicide or euthanasia)

• Non-suicidal self-injury

• Mental illnesses not directly related to suicidal behaviour.

(18)

Methodology: Constitution of reference library

PubMed Search 2,638 hits

CINAHL Search 818 hits PsychINFO Search

1,064 hits

Merged EndNote Library 4,520 hits

Merged EndNote Library 3,785 hits

Duplicates

734 removed Duplicates

243 Removed

Merged EndNote Library 3,542 hits

“Find Duplicates” Manual search for

duplicates

• Literature search yielded an extremely high number of hits due to large scope of project

• Decisions to move forward:

o Focus on only systematic reviews and meta-analyses o Exclusion of country-specific data

o Conduct as a scoping review: less emphasis on specific findings, more emphasis on where the bulk of the literature is

(19)

Methodology: Constitution of reference library

PubMed Search 2,638 hits

CINAHL Search 818 hits PsychINFO Search

1,064 hits

Merged EndNote Library 4,520 hits

Merged EndNote Library 3,785 hits

Duplicates

734 removed Duplicates

243 Removed

Merged EndNote Library 3,542 hits

“Find Duplicates” Manual search for

duplicates

Biological factors 62 articles

Sort into categories (multiple categories allowed) Clinical & social factors

511 articles

Epidemiology 82 articles

Service research 25 articles Treatment & interventions

175 articles Prevention & Screening

172 articles

Meta- analyses

(MA):

382 identified

Systematic reviews (SR):

679; 485 distinct from

MA Irrelevant

22 MA; 41 SR; 27 not SR

Country-specific 14 MA; 13 SR; 6 not SR Identify themes of interest

and analyze articles

Follow-up & Postvention 28 articles

(20)

Methodology: Further clean-up of library

Article titles grouped into relevant themes then analyzed individually

Exclusions due to:

Lack of relevance or specific focus on a non-NA population

Lack of clear methodology (not a systematic review, demoted from 4-5 star system to a single star)

Resort to more appropriate category

Canadian authorship and content of articles was reported

“Authorship” : author (s) of the review had Canadian affiliation

“Content”: article overtly referred to Canadian data

• Main findings: compendium of data reported by authors of the meta-analyses (and sometimes SRs)

Recommendations: authors’ recommendations as to orientation of

future research activities or changes to the way in which we approach

suicide and suicidal behaviour

(21)

Methodology: Limitations of the literature review

• Inclusion of only articles that synthesize original research in systematic way (meta-analyses and systematic review)

• No expert reviews, no primary publications

• Consensus data, but bias against certain subject areas

• Bias toward quantitative research in scientific journals

Used complementary databases

Several included studies used qualitative approaches and

specifically mentioned the inclusion of grey literature

(22)

Methodology: Limitations of the literature review

• Major findings and recommendations:

For most sections, drawn from MAs only

When few articles available, drawn from MAs and SRs

• SRs and MAs identified by querying library of over 3,500 articles using keywords – risk of omission keywords not used

• Some areas of research do not produce SRs and Mas

(23)

Methodology: Limitations of the literature review

• Canadian data identified based on author reports in the full-text

Cases where country of origin of primary studies not reported

important Canadian data was included in some of the

systematic reviews and meta-analyses but were not formally identified as Canadian in origin.

• Canadian authorship: authors of SRs and MAs not necessarily the

drivers of original research in the field described

(24)

R ESULTS OF L ITERATURE S EARCH

(25)

Results: Summary of risk factors

Male (S) Female (SB) Adolescent History of SB

Family history of psychiatric disorder/suicide Exposure to violence

Bullying

Child abuse

Season – spring/summer Alcohol/drug use

People receiving inpatient care Incarceration

Internet and media information

Exposure to sensationalized celebrity suicide Comorbid disorders

Psychiatric disorders

Affective disorders (depression)

Substance use disorders

Psychotic disorders

Personality disorders (borderline personality disorder)

Anorexia nervosa

Post-traumatic stress disorder

Bipolar (children and youth)

Attention-deficit disorder (children and youth)

Conduct disorder (children and youth) Other brain disorders

Traumatic brain disorder

Intellectual disabilities

Autism spectrum disorders

Multiple sclerosis

Epilepsy

Cognitive deficit or decline (elderly)

(26)

Results: Summary of risk factors

Somatic conditions

Underweight

Physical pain (any type) (SI/SB)

Previous abortion (SB)

HIV+ (SI and SH) Minority groups

Country of origin of immigrants

Lesbian, gay, bisexual

Indigenous especially youth Occupation

Physician especially female

Police, first-responders Socio-economic situation

Marital status – young, unmarried (SB)

Socio-economic insecurity

Unemployment

Lower education

Family structure

Maternal emotional unavailability

Separated or divorced

Personality and psychological traits

Hopelessness

Impulsivity

Neuroticism

Anxiety

Other social factors

Loneliness

Recent life events

(27)

Results: Summary of protective factors

Internet and media information Somatic conditions

Overweight Minority groups

Country of origin of immigrants

Socio-economic situation

Loving parent-child relationships

Other social factors

Having reasons for living

Social connectedness

Sense of belonging

Religion

Treatment

SSRIs

Ketamine

Lithium for mood disorders

Dialectical-behavioural therapy (DBT)

Internet-based CBT in depression

Follow-up interventions

Active contact and follow-up

(28)

Results: Recommendations for future research

• Produce more data:

To better understand mechanisms leading to suicidal behavior

To support appropriate treatment and follow-up of youth, ethnic/cultural minorities, sexual minorities, and the elderly

To better understand subgroups that are more vulnerable to suicide and SB should be better studied

• Prediction of suicide risk remains elusive

Further characterize differences in subpopulations of individuals with high suicide risk (e.g. schizophrenia vs. major depression)

Follow-up on biological and clinical factors that have been identified and assessed for predictive value

(29)

Results: Recommendations for future research

• Prevention and intervention trials: promising findings, but often inconclusive due to methodologic inconsistencies or inadequate reporting of trial information

• Adequately powered, longitudinal studies incorporating bio-

psychosocial variables are required and should be conducted over longer periods of time

• Harmonize methodology across studies, regardless of research theme

 Improve comparisons and conclusions

 Improve likelihood of inclusion in SRs and MAs

 Facilitate policy changes and

public health initiatives with

strong evidence

(30)

Acknowledgements

The RQSHA is a research network directed by Gustavo Turecki, MD, PhD, and funded by:

This work was commissioned by:

(31)

Questions? Comments?

(32)

Next Suicide Prevention Webinar Date: June 10, 2-3pm EST: How can we help decrease

physician burnout and support professional practice?

Strategies to improve physician engagement, wellness, and excellence.

To re-watch or share this webinar visit:

https://www.mentalhealthcommission.ca/English/initiatives/11885/suicide- prevention-webinar-series-archive

(33)

How did we do?

Please fill out the survey

that opens after you leave

the webinar

(34)

Thank you

#suicideprevention

Karla Thorpe

Director, Prevention and Promotion Initiatives Mental Health Commission of Canada

webinar@mentalhealthcommission.ca

Dr. Sylvanne Daniels

Coordinator, Quebec Network on Suicide, Mood Disorders, and Related Disorders

Douglas Research Centre

#sharehope

Références

Documents relatifs

One systematic review [49] concerning 20 studies (10/20 were double-blind RCTs) reported a synthetic assessment of the effectiveness of weight restoration and interventional

To help health professionals to better assess the risk of cross-reactivity with cephalosporins and carbapenems in penicillin-allergic patients, INESSS conducted two

The analyses stratified according to the probiotic formulation shows that the scientific evidence of the benefits for preventing CDAD, both in adults and children, is insufficient

Individual meta-graphs for responder outcomes for the longest reported outcomes, as well as subgroup analyses of size, funding, and duration are available from CFPlus (Figures A1

-pharmacotherapeutic management of OUD (buprenor- phine, methadone, naltrexone, and cannabinoids), -prescribing practices (use of daily witnessed inges- tion, urine drug testing,

For the adverse events systematic review, system- atic reviews of RCTs with meta-analysis focused on the harms of medical cannabinoids or systematic reviews of RCTs with

Many health care journals, including Canadian Family Physician, publish systematic reviews, but the best-known source is the Cochrane Collaboration, in which a group

It  is  difficult  to  know  from  this  review  whether  the  relative  effectiveness  of  the  lower  dosage  of